Prof. Dr. med. Carola Berking

Lehrstuhl für Haut- und Geschlechtskrankheiten

Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS (2021) Gutzmer R, Schulze HJ, Hauschild A, Leiter U, Meier F, Haferkamp S, Ulrich C, et al. Journal article Factors influencing the adjuvant therapy decision: Results of a real-world multicenter data analysis of 904 melanoma patients (2021) Lodde G, Forschner A, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, et al. Journal article Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Dermatooncology Group (2021) Grimmelmann I, Momma M, Zimmer L, Hassel JC, Heinzerling L, Pföhler C, Loquai C, et al. Journal article Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition (2021) Knispel S, Gassenmaier M, Menzies AM, Loquai C, Johnson DB, Franklin C, Gutzmer R, et al. Journal article Online-Konsensuskonferenzen für die Entwicklung und Aktualisierung von Leitlinien für die klinische Praxis: Eine Umfrage unter den Teilnehmenden der deutschen S3-Leitlinie zur aktinischen Keratose und kutanem Plattenepithelkarzinom (2021) Steeb T, Follmann M, Langer T, Nothacker M, Wessely A, Garbe C, Leiter U, et al. Journal article Hematological immune related adverse events after treatment with immune checkpoint inhibitors (2021) Kramer R, Zaremba A, Moreira A, Ugurel S, Johnson DB, Hassel JC, Salzmann M, et al. Journal article Preclinical evaluation of a combination of checkpoint blockade and dendritic cell vaccination against Merkel cell carcinoma (2021) Sauerer T, Gerer K, Hoyer S, Erdmann M, Berking C, Voll R, Schuler-Thurner B, et al. Conference contribution Brn3a expression is epigenetically controlled by HDAC2 in melanocytes and melanoma (2021) Heppt M, Wessely A, Hornig E, Kammerbauer C, Graf S, Besch R, French LE, et al. Conference contribution BRAF and MEK inhibitors affect dendritic cell maturation and T cell stimulation (2021) Hoyer S, Eberlein V, Schuler G, Berking C, Heinzerling L, Schaft N, Dörrie J Conference contribution Inhibiting the neural crest transcription factor SOX10 leads to cell cycle arrest and apoptosis in uveal melanoma cells (2021) Wessely A, Kammerbauer C, Lischer C, Vera González J, Berking C, Heppt M Conference contribution